Neural adhesion molecule NECL1 inhibits migration, invasion, and potentially induces differentation of glioma cell

Acta Academiae Medicinae Sinicae

Volumn 31, Issue 6, 2009, Pages 669-673

  Yin, Bin ^a   Chen, Tao ^a   Gao, Jing ^a   Yuan, Jian Gang ^a   Peng, Xiao Zhong ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Astrocytes; Invasion; Migration; NECL1; U251 glioma cell lines

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE NECL1; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL STRAIN U251; CELL STRUCTURE; GLIOMA CELL; HUMAN; HUMAN CELL; NERVE CELL; PROTEIN FUNCTION; UPREGULATION; WESTERN BLOTTING;

BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; NEURAL CELL ADHESION MOLECULES;

EID: 75749148002     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2009.06.003     Document Type: Article

References (19)

1. Goto A, Niki T, Chi-Pin L, et al. Loss of TSLC1 expression in lung adenocarcinoma; relationships with histological subtypes, sex and prognostic significance [J]. Cancer Sci, 2005, 96(8):480-486.
2. Houshmandi SS, Surace EI, Zhang HB, et al. Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor [J]. Neurology, 2006, 67(10):1863-1866.
3. Ito T, Shimada Y, Hashimoto Y, et al. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma [J]. Cancer Res, 2003, 63(19):6320-6326.
4. Kuramochi M, Fukuhara H, Nobukuni T, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer [J]. Nat Genet, 2001, 27(4):427-430.
5. Lung HL, Cheung AK, Xie D, et al. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma [J]. Cancer Res, 2006, 66(19):9385-9392.
6. Steenbergen RD, Kramer D, Braakhuis BJ, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia [J]. J Natl Cancer Inst, 2004, 96(4):294-305.
7. Surace EI, Lusis E, Murakami Y, et al. Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival [J]. J Neuropathol Exp Neurol, 2004, 63(10):1015-1027.
8. Usami Y, Ito A, Ohnuma K, et al. Tumor suppressor in lung cancer-1 as a novel ameloblast adhesion molecule and its downregulation in ameloblastoma [J]. Pathol Int, 2007, 57(2):68-75.
9. Mao X, Seidlitz E, Truant R, et al. Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth [J]. Oncogene, 2004,23(33):5632-5642.
10. Masuda M, Kikuchi S, Maruyama T, et al. Tumor suppressor in lung cancer (TSLC) 1 suppresses epithelial cell scattering and tubulogenesis [J]. J Biol Chem, 2005, 280(51):42164-42171.
11. Sussan TE, Pletcher MT, Murakami Y, et al. Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression [J]. Mol Cancer, 2005, 4:28.
12. Chadeneau C, Denis MG, Blottiere HM, et al. Characterization, isolation and amino terminal sequencing of a rat colon carcinoma-associated antigen [J]. Int J Cancer, 1991, 47(6):903-908.
13. Douillard JY, Laborda J, Burg C, et al. Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors [J]. Cancer Res, 1989, 49(3):687-692.
14. Sloan KE, Stewart JK, Treloar AF, et al. CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics [J]. Cancer Res, 2005, 65(23):10930-10937.
15. Ikeda W, Kakunaga S, Takekuni K, et al. Nectin-like molecule-5/Tage4 enhances cell migration in an integrin-dependent, Nectin-3-independent manner [J]. J Biol Chem, 2005, 279(17):18015-18025.
16. Fukuhara H, Kuramochi M, Nobukuni T, et al. Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins [J]. Oncogene, 2001, 20(38):5401-5407.
17. Gao J, Chen T, Liu J, et al. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-trichostatin A through Sp1 binding site [J]. Glia, 2009, 57(9):989-999.
18. Okada Y. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis [J]. Verh Dtsch Ges Pathol, 2000, 84(1):33-42.
19. Levicar N, Nuttall RK, Lah TT. Proteases in brain tumour progression [J]. Acta Neurochir (Wien), 2003, 145(9):825-838.